RoukenBio and AVS Bio have formed a strategic partnership aimed at streamlining the development of therapeutic antibodies.
NEW HAVEN, Conn.--(BUSINESS WIRE)--Weave Bio, an AI-native life sciences platform company, announced the public release of its flagship offering, AutoIND, and seed funding of $10M co-led by Innovation ...
A Japan-based biopharma company with two operating pillars: a biosimilars business (development and supply of approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results